Literature DB >> 21911105

Prospective study of maternal depressive symptomatology among Japanese women.

Naoko Ishikawa1, Setsuko Goto, Satomi Murase, Atsuko Kanai, Tomoko Masuda, Branko Aleksic, Hinako Usui, Norio Ozaki.   

Abstract

BACKGROUND: The primary objective of this study was to analyze the pattern of depressive moods related to pregnancy and postpartum in a dataset collected prospectively. A secondary objective was to assess the association between (1) low moods during pregnancy and postpartum depressive symptoms, and (2) maternity blues and postpartum depressive symptom.
METHOD: Three hundred eighty-seven women completed self-administered questionnaires. The participants were asked to respond to Stein's Maternity Blues Scale (Stein's Scale) on five consecutive days after delivery and to the Edinburgh Postnatal Depression Scale (EPDS) during both pregnancy and postpartum.
RESULTS: 32.0% of the women were identified as having a score of more than 9 on EPDS during pregnancy and postpartum. 21.6% of the women scored above the Stein's Scale cut-off point for at least 1 day during the 5-day period following delivery. The odds ratio (95% CI) for postpartum low mood if the women experienced low mood during pregnancy was 4.46 (2.48-8.04), while the odds ratio for postpartum depressive symptoms if the women experienced symptoms of maternity blues was 5.48 (2.74-10.98). In logistic regression analysis, the number of days in which women scored over the cut-off point by Stein's Scale proved to be the more significant predictor of scoring over the EPDS cutoff (8/9) [OR (95% CI)=2.74 (1.89-3.96)].
CONCLUSION: The rate of maternity blues in our findings was similar to the rates previously reported in Japan, but lower than the rates observed in Western countries. Furthermore, our longitudinal study confirms the likelihood of subsequent postpartum depressive symptoms if low moods during pregnancy and/or maternity blues are present.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21911105     DOI: 10.1016/j.jpsychores.2011.02.001

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  15 in total

Review 1.  Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5.

Authors:  Kazuyoshi Ogasawara; Yukako Nakamura; Hiroyuki Kimura; Branko Aleksic; Norio Ozaki
Journal:  J Neural Transm (Vienna)       Date:  2017-12-23       Impact factor: 3.575

2.  Prospective study on the association between harm avoidance and postpartum depressive state in a maternal cohort of Japanese women.

Authors:  Kaori Furumura; Takayoshi Koide; Takashi Okada; Satomi Murase; Branko Aleksic; Norika Hayakawa; Tomoko Shiino; Yukako Nakamura; Ai Tamaji; Naoko Ishikawa; Harue Ohoka; Hinako Usui; Naomi Banno; Tokiko Morita; Setsuko Goto; Atsuko Kanai; Tomoko Masuda; Norio Ozaki
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

3.  Relationship between social support during pregnancy and postpartum depressive state: a prospective cohort study.

Authors:  Mako Morikawa; Takashi Okada; Masahiko Ando; Branko Aleksic; Shohko Kunimoto; Yukako Nakamura; Chika Kubota; Yota Uno; Ai Tamaji; Norika Hayakawa; Kaori Furumura; Tomoko Shiino; Tokiko Morita; Naoko Ishikawa; Harue Ohoka; Hinako Usui; Naomi Banno; Satomi Murase; Setsuko Goto; Atsuko Kanai; Tomoko Masuda; Norio Ozaki
Journal:  Sci Rep       Date:  2015-05-29       Impact factor: 4.379

4.  Factor structure of the Japanese version of the Edinburgh Postnatal Depression Scale in the postpartum period.

Authors:  Chika Kubota; Takashi Okada; Branko Aleksic; Yukako Nakamura; Shohko Kunimoto; Mako Morikawa; Tomoko Shiino; Ai Tamaji; Harue Ohoka; Naomi Banno; Tokiko Morita; Satomi Murase; Setsuko Goto; Atsuko Kanai; Tomoko Masuda; Masahiko Ando; Norio Ozaki
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

Review 5.  Prevalence of perinatal depression among Japanese women: a meta-analysis.

Authors:  Keita Tokumitsu; Norio Sugawara; Kazushi Maruo; Toshihito Suzuki; Kazutaka Shimoda; Norio Yasui-Furukori
Journal:  Ann Gen Psychiatry       Date:  2020-06-26       Impact factor: 3.455

6.  Validation and Factor Analysis of the Japanese Version of the Highs Scale in Perinatal Women.

Authors:  Aya Yamauchi; Takashi Okada; Masahiko Ando; Mako Morikawa; Yukako Nakamura; Chika Kubota; Masako Ohara; Satomi Murase; Setsuko Goto; Atsuko Kanai; Norio Ozaki
Journal:  Front Psychiatry       Date:  2018-06-28       Impact factor: 4.157

7.  Interaction effect of oxytocin receptor (OXTR) rs53576 genotype and maternal postpartum depression on child behavioural problems.

Authors:  Damee Choi; Kenji J Tsuchiya; Nori Takei
Journal:  Sci Rep       Date:  2019-05-22       Impact factor: 4.379

8.  Methylation analysis for postpartum depression: a case control study.

Authors:  Yukako Nakamura; Masahiro Nakatochi; Shohko Kunimoto; Takashi Okada; Branko Aleksic; Miho Toyama; Tomoko Shiino; Mako Morikawa; Aya Yamauchi; Akira Yoshimi; Yoko Furukawa-Hibi; Taku Nagai; Masako Ohara; Chika Kubota; Kiyofumi Yamada; Masahiko Ando; Norio Ozaki
Journal:  BMC Psychiatry       Date:  2019-06-20       Impact factor: 3.630

9.  Relation Between Perinatal Depressive Symptoms, Harm Avoidance, and a History of Major Depressive Disorder: A Cohort Study of Pregnant Women in Japan.

Authors:  Chika Kubota; Toshiya Inada; Tomoko Shiino; Masahiko Ando; Branko Aleksic; Aya Yamauchi; Maya Sato; Masako Ohara; Satomi Murase; Mako Morikawa; Yukako Nakamura; Takashi Okada; Setsuko Goto; Atsuko Kanai; Norio Ozaki
Journal:  Front Psychiatry       Date:  2019-07-26       Impact factor: 4.157

10.  The postpartum depressive state in relation to perceived rearing: a prospective cohort study.

Authors:  Norika Hayakawa; Takayoshi Koide; Takashi Okada; Satomi Murase; Branko Aleksic; Kaori Furumura; Tomoko Shiino; Yukako Nakamura; Ai Tamaji; Naoko Ishikawa; Harue Ohoka; Hinako Usui; Naomi Banno; Tokiko Morita; Setsuko Goto; Atsuko Kanai; Tomoko Masuda; Norio Ozaki
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.